Cell Cryopreservation Market, By Product Type (Cryopreservative Medium (Glycerol, Dimethyl sulfoxide (DMSO), and Others), Freezers, and Others), By Application (Stem cells, Oocytes and embryos, Sperm, Semen, and Testicular Tissue, and Others), By End User (Pharmaceutical and Biotechnology Companies, Research Institutes, and Others), and By Region (North America, Latin America, Europe, Middle East, Asia Pacific, Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI2018 | Publish Date: April 2024 | No. of Pages: 180

Global Cell Cryopreservation Market By Overview

Introduction:

Cell Cryopreservation   Market was valued at US$ 11.1 Billion in 2024 and is projected to grow at a CAGR of 21.00% to reach US$ 75.1 Billion by 2034.

Cryopreservation is the technique of freezing tissues and cells at low temperatures, i.e. -80 °C using solid CO2 or -196 °C using liquid nitrogen. To keep the biological material metabolically inert, retain their structure, to maintain its viability, and to prevent ice crystal formation due to low temperature. The cells are preserved in the cryopreservation media that consists of base medium, cryopreservative and a protein source.

Global Cell Cryopreservation Market By Dynamics

Drivers

Restrains

Cell preservation such as stem cells, oocytes

Alternatives cell preservation methods

New product launches of novel cryopreservation systems.

 

Advancements in cellular therapy research

 

Government financing for R&D activities 

 

Establishment of Biobanks

 

Regional Insights:                                                                                                                             

On region the target market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa

  • North America market is estimated to witness a significantly high revenue share over the forecast period.

                o Advanced medical infrastructure

                 o Significant players in biopharmaceutical industry

                 o Established supply channels

  • Asia Pacific market is estimated to witness a fastest revenue share over the forecast period.

                 o Adoption of cell preservation technologies

                 o Surge in rate of infertility

 

Global Cell Cryopreservation Market By Segmentation

Dividing this target market into segments:

Cell cryopreservation market is segmented based on Product Type, Application, End-user and Region.

Product Type Insight

On the basis of Product Type, the target market is segmented into Cryopreservative Medium (Glycerol, Dimethyl sulfoxide (DMSO), and Others), Freezers, and Others

Application Insight

On the basis of Application, the target market is segmented into Stem cells, Oocytes and embryos, Sperm, Semen, and Testicular Tissue, and Others

End-user Insight

On the basis of End-user, the target market is segmented into Pharmaceutical and Biotechnology Companies, Research Institutes, and Others.

Report Scope:

Attribute

Details

Base year for estimation

2023

Forecast period

2024 – 2034

Market representation

Revenue in USD Billion & CAGR from 2024 to 2034

Market Segmentation

By Product Type – Cryopreservative Medium (Glycerol, Dimethyl sulfoxide (DMSO), and Others), Freezers, and Others

By Application - Stem cells, Oocytes and embryos, Sperm, Semen, and Testicular Tissue, and Others

By End-users - Pharmaceutical and Biotechnology Companies, Research Institutes, and Others.

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034.

 

Global Cell Cryopreservation Market By Key Players

The key players operating in the cell cryopreservation market Merck KGaA, GE Healthcare, Thermo Fisher Scientific, Inc., AMS Biotechnology Limited, Nippon Genetics, VitriCell SA, MiltenyiBiotec, Mediatech, Inc., BioLifeSolutions, Inc., HiMedia Laboratories, and PromoCell GmbH.

Global Cell Cryopreservation Market By Key Issues Addressed

Recent Development:

The New Launched Product News,

  • In June 2023, BioLife Solutions, Inc., a global biotechnology company, announced the launch of a new, large-capacity controlled-rate freezer (CRF) to expand its CRF product line, which now stands at three different form factors. Branded as the IntelliRate i67C, this tabletop freezer caters to a crucial customer need for higher volume production of cell therapies.
  • In May 2022, Bristol Myers Squibb Receives European Commission Approval for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Certain Forms of Relapsed or Refractory Large B-cell Lymphoma. Breyanzi represents a differentiated CAR T cell therapy with demonstrated rapid and durable complete responses and a manageable safety profile.

Global Cell Cryopreservation Market By Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Preview
    • Executive Summary
    • Key Findings—Global Outlook for medical carts Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Product Type
      • Market Snippet, By End User
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restrains
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis

Cell Cryopreservation Market, By Product Type, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Cryopreservative Medium
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Glycerol
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Dimethyl sulfoxide
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Cell Cryopreservation Market, By Application, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Stem cells
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Oocytes and embryos
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Sperm
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Semen and Testicular tissue
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Others
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  1. Cell Cryopreservation Market, By End User, Forecast Period up to 10 Years, (US$ Bn)
  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Pharmaceutical and Biotechnology Companies
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Research Institutes
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Others
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  1. Cell Cryopreservation Market, By Region, Forecast Period up to 10 Years, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
      • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
    • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • GCC
      • Israel
      • South Africa
      • Rest of Middle East
  1. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  2. Company Profiles 
  • Heat Map Analysis
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Market Presence and Specificity Analysis
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Competitive Overview
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Competitive Benchmarking
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Market Share Analysis
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Key Developments In The Cell Cryopreservation Market
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Key Developments: Mergers & Acquisitions
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Key Developments: Collaboration
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Key Developments: Contracts & Agreements
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Key Developments: Expansion
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

Global Cell Cryopreservation Market is segmented, By Product Type (Cryopreservative Medium (Glycerol, Dimethyl sulfoxide (DMSO), and Others), Freezers, and Others), By Application (Stem cells, Oocytes and embryos, Sperm, Semen, and Testicular Tissue, and Others), and By End User (Pharmaceutical and Biotechnology Companies, Research Institutes, and Others)

Increasing number product launches of novel cryopreservation systems are expected to drive the cell cryopreservation market

The key players operating in the global cell cryopreservation market Merck KGaA, GE Healthcare, Thermo Fisher Scientific, Inc., AMS Biotechnology Limited, Nippon Genetics, VitriCell SA, MiltenyiBiotec, Mediatech, Inc., BioLifeSolutions, Inc., HiMedia Laboratories, and PromoCell GmbH.

The market for Low Calorie Food was valued at US$ 8659.6 million in 2022 and is projected to grow at a CAGR of 22.6% to reach US$ 65113.3 million by 2032.